Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-05-15
2011-12-06
Layno, Carl H (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S003000, C604S522000, C424S078080
Reexamination Certificate
active
08073538
ABSTRACT:
To control cardiac arrhythmias such as atrial fibrillation post-operatively, various non-ablative agents include polymers, fibroblasts, neurotoxins, and growth factors are introduced into one or more cardiac fat pads into the atrioventricular nodal fat pad in proximity to the autonomic ganglia therein. Any desired technique may be used for introducing the agent, including injection. The sinoatrial nodal fat pad target site and the atrioventricular nodal fat pad target site are identified using a stimulator, which may have electrodes coupled thereto or which may coupled to electrodes built into a delivery system.
REFERENCES:
patent: 4874368 (1989-10-01), Miller et al.
patent: 5709854 (1998-01-01), Griffith-Cima et al.
patent: 5951484 (1999-09-01), Hoium et al.
patent: 6059726 (2000-05-01), Lee et al.
patent: 6136334 (2000-10-01), Veigas et al.
patent: 6151525 (2000-11-01), Soykan et al.
patent: 6292695 (2001-09-01), Webster, Jr. et al.
patent: 6425918 (2002-07-01), Shapiro et al.
patent: 6454739 (2002-09-01), Chang
patent: 6544503 (2003-04-01), Vanderhoff et al.
patent: 6630457 (2003-10-01), Aeschlimann et al.
patent: 6696575 (2004-02-01), Schmidt et al.
patent: 6699471 (2004-03-01), Radice et al.
patent: 6767544 (2004-07-01), Brooks et al.
patent: 6932804 (2005-08-01), Lee
patent: 2003/0104568 (2003-06-01), Lee
patent: 2004/0002740 (2004-01-01), Lee
patent: 2004/0005295 (2004-01-01), Lee et al.
patent: 2004/0106896 (2004-06-01), Lee et al.
patent: 2004/0143238 (2004-07-01), Lee
patent: 2004/0242469 (2004-12-01), Lee et al.
patent: 2005/0003010 (2005-01-01), Cohen et al.
patent: 2005/0010263 (2005-01-01), Schauerte
patent: 2005/0119704 (2005-06-01), Peters et al.
patent: 2006/0083717 (2006-04-01), Lee et al.
patent: 2006/0200207 (2006-09-01), Thrope et al.
patent: 2006/0200219 (2006-09-01), Thrope et al.
patent: WO 99/15211 (1999-04-01), None
patent: 99/48545 (1999-09-01), None
patent: WO 99/60923 (1999-12-01), None
patent: 01/34088 (2001-05-01), None
patent: WO 03/026480 (2003-04-01), None
patent: WO 03/094855 (2003-11-01), None
patent: WO 03/095016 (2003-11-01), None
patent: WO 2004/050013 (2004-06-01), None
patent: WO 2004/050013 (2004-06-01), None
patent: WO 2005/049111 (2005-06-01), None
European Patent Office, Extended European Search Report for Application No. 07794897.4, May 27, 2009, 7 pages.
Allergan, Inc., Botox: Mechanism of Action, Nov. 12, 2004 (date is when retrieved from the Internet site http://www.botox.com/site/professionals/product—info/mechanism—of—action.asp), 10 pages.
Amour, J. Andrew, et al., Gross and Microscopic Anatomy of the Human Intristic Cardiac Nervous System, The Anatomical Record, vol. 247, 1997, pp. 289-298.
Baxter AG, Duplocath Application Catheter, 1999, 2 pages.
Baxter Healthcare Corporation, CoSeal Surgical Sealant: Use Instructions, Mar. 2003, 2 pages.
Campbell, Patrick K., et al., Evaluation of Absorbable Surgical Sealants: In vitro Testing, White Paper, 2005, 4 pages.
Carlson, Mark D., et al., Selective Stimulation of Parasympathetic Nerve Fibers to the Human Sinoatrial Node, Circulation, vol. 85, No. 4, Apr. 1992, pp. 1311-1317.
Christman, Karen L., et al., Injectable Fibrin Scaffold Improves Cell Transplant Survival, Reduces Infarct Expansion, and Induces Neovasculature Formation in Ischemic Myocardium, Journal of the American College of Cardiology, vol. 44, No. 3, Aug. 2004, 8 pages.
Cummings, MD, Jennifer E., et al., Preservation of the Anterior Fat Pad Paradoxically Decreases the Incidence of Postoperative Atrial Fibrillation in Humans, Journal of the American College of Cardiology, vol. 43, No. 6, Mar. 2004, pp. 994-1000.
Dickneite, Gerhard, et al., A comparison of fibrin sealants in relation to their in vitro and in vivo properties, Thrombosis Research, vol. 112, 2003, pp. 73-82.
Gospodarowicz, Denis, Fibroblast Growth Factor Chemical Structure and Biologic Function, Clinical Orthopedics and Related Research, No. 257, Aug. 1990, pp. 231-248.
Hirose, MD, Masamichi, et al., Partial Vagal Denervation Increases Vulnerability to Vagally Induced Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, vol. 13, No. 12, Dec. 2002, pp. 1272-1279.
Iqbal, Yasmine, What's New in Wound Closures, Outpatient Surgery Magazine, Oct. 2002, 2 pages.
Kong, Hyun-Joon, et al., Controlling Material Properties of lonically Cross-Linked Alginate Hydrogels by Varying Molecular Weight Distribution, Mat. Res. Soc. Symp. Proc., vol. 711, 2002, pp. GG5.7.1-GG5.7.4.
Lazzara, Ralph, et al., Selective In Situ Parasympathetic Control of the Canine Sinoatrial and Atrioventricular Nodes, Circulation Research, vol. 32, Mar. 1973, pp. 393-401.
Leung, Jacqueline M., et al., Impairment of left atrial function predicts post-operative atrial fibrillation after coronary artery bypass graft surgery, European Heart Journal, vol. 25, 2004, pp. 1836-1844.
Marrouche, MD, Nassir F., Temporary Modification of the Epicardial Fat Pads in Patients Undergoing Low to Moderate Risk Open Heart Surgery: Safety and Efficacy of a Novel Approach for Lowering the Incidence of Post Operative Atrial Fibrillation, Heart Rhythm, vol. 3, No. 5, May 2006, pp. S148-S149 (abstract).
Mazgalev, Todor N., AV Nodal Physiology, NASPE-Heart Rhythm Society, undated, 12 pages (downloaded from www.naspe.org/professional—education).
McGuirt, A. S., et al., Autonomic interactions for control of atrial rate are maintained after SA nodal parasympathectomy, Am. J. Physiol. 272 (Heart Circ. Physiol. 41), 1997, H2525-H2533.
Melo, MD, J., et al., Ventral cardiac denervation reduces the incidence of atrial fibrillation after coronary artery bypass grafting, The Journal of Thoracic and Cardiovascular Surgery, vol. 127, No. 2, Feb. 2004, pp. 511-516.
Moulton, Linda C., A Minimally Invasive Approach to the Treatment of Atrial Fibrillation: The Mini-Maze, EP Lab Digest, vol. 5, No. 11, Nov. 2005, pp. 1-6 & 8.
NovaMatrix, Sodium Hyaluronate Pharma Grade 200, Product Specification Bulletin, 2002, 2 pages.
O'Donnell, MD, Sean D., et al., Evaluation of a New Hydrogel Vascular Sealant: In-vitro and In-vivo Test Results, White Paper, 2005, 4 pages.
Oz, MD, Mehmet C., et al., Controlled Clinical Trial of a Novel Hemostatic Agent in Cardiac Surgery, Ann Thorac Surg, vol. 69, 2000, pp. 1376-1382.
Page, P., et al., Neurally Induced Atrial Fibrillation: Differences Between Stimulation of the Vagal Nerve and a Discrete Intrapericardial Nerve, Feb. 17, 2005 (date is when retrieved from the Internet site http://www.pulsus.com/ccc2004/abs/a152.htm). 1 page.
Pappone, Carlo, et al., Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation of Paroxysmal Atrial Fibrillation, Circulation, vol. 109, 2004, 8 pages.
Pauza, Dainius H., et al., Morphology, Distribution, and Variability of the Epicardiac Neural Ganglionated Subplexuses in the Human Heart, The Anatomical Record, vol. 259, 2000, pp. 353-382.
Platt, MD, Marc, et al., Identification and Ablation of Pulmonary Vein Ganglia (Fat Pad): Atrial Fibrillation Substrate alteration as a Guide to Successful Radiofrequency Balation of Persistent Atrial Fibrillation. PACE. vol. 26. No. 4. Apr. 2003. p. 1117.
Platt, MD, Marc, et al. Limiting the Number and Extent of Radiofrequency Applications to Terminate Atrial Fibrillation and Subsequently Prevent its Inducibility (Abstract), NASPE Heart Rhythm Society, (undated), 1 page.
Quan, MD, Kara J., et al., Identification and Characterization of Atrioventricular Parasympathetic Innervation in Humans, Journal of Cardiovascular Electrophysiology, vol. 13, No. 8, Aug. 2002, pp. 735-739.
R&D Systems, 1996 Catalog: Fibroblast Growth Factor 9, 2 pages, (Retrieved from the Internet <URL: http://www.mdsystems.com/asp/g—sitebuilder.asp?bBodyOnly=1&bodyID=199).
R&D Systems, 2001 Catalog: Fibroblast Growth Factors, 9 pages, (Retrieved from the Internet <URL: http://www.mdsystems.com/asp/g—SiteBuilder.asp?bBodyOnly=1&BodyID=308).
Saltman, MD, Adam E., New Onset postoperative atrial fibrillation: A riddle wrapped in a mystery inside an enigma, The Jou
Maciejewski Mark
Mazgalev Todor N.
Peters Nicholas S.
Cardio Polymers, Inc.
Carroll David H.
Layno Carl H
Lee Yun Haeng
LandOfFree
Treatment of cardiac arrhythmia by modification of neuronal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cardiac arrhythmia by modification of neuronal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cardiac arrhythmia by modification of neuronal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298161